Welcome to datamethods [general] (2)
Propensity matching and analysis of resultant data on a data set with nonuniform repeated measures [modeling strategy] (6)
Statistics Reform ( 2 ) [general] (39)
Dealing with missing outcome data in prediction models [data analysis] (6)
"Voracious demand for data" of pure probabilistic reasoning [design] (2)
Statistics in the era of big data [general] (4)
Bayesian Re-Analysis of Clinical Trial Data [general] (12)
Robust Estimation of Marginal Effects (and Uncertainty) using Bayesian Additive Regression Trees [uncertainty] (1)
The Future of Scientific Publishing ( 2 3 ) [peer review] (57)
Competing risks analysis with multiple non-competing events [general] (6)
Modelling outcome data with a limit of detection. Is a hurdle model appropriate? [modeling strategy] (16)
RCT of calcium supplementation to prevent pre-eclampsia. Huge conditional outcomes issue - what's the best analysis? [research methods] (6)
What does it mean when a test/predictor is 'predictive on the aggregate level but not on the individual level' [study interpretation] (4)
Relation between autocovariance and spectral density in time series analysis [statistical] (2)
Cumulative toxicity endpoint opinion [design] (4)
Biostatisticians, have you ever rounded in the hospital with a clinical team or observed some days of work in a clinic? [general] (14)
Misleading results from subgroup analysis combined with regression to the mean in crossover RCT’s [general] (4)
ANDROMEDA-SHOCK (or, how to intepret HR 0.76, 95% CI 0.55-1.02, p=0.06) ( 2 3 4 ) [general] (67)
Practical challenges of individualizing prognosis/risk [general] (3)
Arguments against reporting adjusted odds ratios as risk ratios [measurement] (6)
Temporal correlation in Emergency Department Crowding [research methods] (2)
Statistical methods for establishing the "insufficiency" of data cutoffs [study interpretation] (1)
Interpretation of the Hazard Ratio in a Cox regression model with time varying covariate(s) [data analysis] (1)
How to use p-values when sample sizes are not fixed [design] (6)
Polygenic Risk Scores Discussion [journal club] (14)
Optimism-correction for Lasso-Cox [model validation] (8)
Proofs of Nulls: P > 0.05 ( 2 ) [study interpretation] (25)
Problems with NNT ( 2 ) [study interpretation] (36)
Comparing healthcare cost between two arms of an RCT [general] (4)
Who to read in snp/gwas/personalised medicine? [data analysis] (4)